Hepatic over-expression of peroxisome proliferator activated receptor γ2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus

被引:177
作者
Rahimian, R
Masih-Khan, E
Lo, M
van Breemen, C
McManus, BM
Dubé, GP
机构
[1] Univ British Columbia, Fac Med, Dept Pathol & Lab Med, St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada
[2] Univ British Columbia, St Pauls Hosp, Vancouver Vasc Biol Res Ctr, Vancouver, BC V5Z 1M9, Canada
基金
英国医学研究理事会;
关键词
adipose; insulin resistance; liver; PCR; PPAR gamma; ob/ob mouse;
D O I
10.1023/A:1011927113563
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
Studies of the molecular basis of insulin resistance have focused on the peroxisome proliferator activated receptor gamma (PPAR gamma, gamma1 and gamma2). The aim of this study was to determine whether the insulin resistance in liver of diabetic animals is associated with abnormal expression of these receptors. PPAR gamma mRNA and protein expression levels were quantified in liver of 9-week-old male ob/ob mice as a model of diabetes and compared to age- and gender-matched wild type control animals of the same genetic background. Semi-quantitative reverse transcription-polymerase chain reaction, using 18S rRNA as an internal standard, indicated that PPAR gamma2 mRNA was significantly upregulated in ob/ob liver vs. that in wild type mice. Western blotting revealed greater immunoreactivity of PPAR gamma2 in liver from ob/ob mice relative to that in wild type mice. An index of insulin resistance (product of serum glucose and insulin concentration) was correlated with liver PPAR gamma2 mRNA expression (r = 0.776; p < 0.001). The findings that liver PPAR gamma2 expression is (1) significantly elevated in the ob/ob model of diabetes and (2) positively associated with an index of insulin resistance, suggests a possible compensatory response through which type II diabetic and obese organisms strive to maintain insulin sensitivity of the liver.
引用
收藏
页码:29 / 37
页数:9
相关论文
共 37 条
[1]
Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients [J].
Auboeuf, D ;
Rieusset, J ;
Fajas, L ;
Vallier, P ;
Frering, V ;
Riou, JP ;
Staels, P ;
Auwerx, J ;
Laville, M ;
Vidal, H .
DIABETES, 1997, 46 (08) :1319-1327
[2]
Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension [J].
Barroso, I ;
Gurnell, M ;
Crowley, VEF ;
Agostini, M ;
Schwabe, JW ;
Soos, MA ;
Maslen, GL ;
Williams, TDM ;
Lewis, H ;
Schafer, AJ ;
Chatterjee, VKK ;
O'Rahilly, S .
NATURE, 1999, 402 (6764) :880-883
[3]
Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: Binding and activation correlate with antidiabetic actions in db/db mice [J].
Berger, J ;
Bailey, P ;
Biswas, C ;
Cullinan, CA ;
Doebber, TW ;
Hayes, NS ;
Saperstein, R ;
Smith, RG ;
Leibowitz, MD .
ENDOCRINOLOGY, 1996, 137 (10) :4189-4195
[4]
BRAISSANT O, 1996, ENDOCRINOLOGY, V137, P345
[5]
CARLOS L, 1989, BASIC HISTOLOGY, P3
[6]
A SIMPLE MEASURE OF INSULIN-RESISTANCE [J].
DUNCAN, MH ;
SINGH, BM ;
WISE, PH ;
CARTER, G ;
ALAGHBANDZADEH, J .
LANCET, 1995, 346 (8967) :120-121
[7]
Edvardsson U, 1999, J LIPID RES, V40, P1177
[8]
The organization, promoter analysis, and expression of the human PPAR gamma gene [J].
Fajas, L ;
Auboeuf, D ;
Raspe, E ;
Schoonjans, K ;
Lefebvre, AM ;
Saladin, R ;
Najib, J ;
Laville, M ;
Fruchart, JC ;
Deeb, S ;
VidalPuig, A ;
Flier, J ;
Briggs, MR ;
Staels, B ;
Vidal, H ;
Auwerx, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) :18779-18789
[9]
ANALYSIS OF A TISSUE-SPECIFIC ENHANCER - ARF6 REGULATES ADIPOGENIC GENE-EXPRESSION [J].
GRAVES, RA ;
TONTONOZ, P ;
SPIEGELMAN, BM .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (03) :1202-1208
[10]
Pathogenesis of insulin resistance in type 2 diabetes - A collision between thrifty genes and an affluent environment [J].
Groop, LC .
DRUGS, 1999, 58 (Suppl 1) :11-12